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Objectives: Patients with atrial fibrillation (AF) have rapid and irregular heart rates, increasing the risk of comorbidities and
mortality. Next to formal medical care, many patients receive informal care from their social environment. The objective of
this study was to examine the well-being and economic burden of providing informal care to patients with AF in the UK, Italy,
and Germany.
Methods: Caregivers of patients with AF completed an online survey based on the iMTA Valuation of Informal Care Ques-
tionnaire, with questions about their caregiving situation, perceived burden of caregiving, and absence from work due to
health problems resulting from caregiving. Care-related quality-of-life utilities were calculated using the Care-related Quality
of Life instrument and associated tariffs. Societal costs of caregiving were calculated based on the proxy good method.
Results: A total of 585 caregivers participated in this study. On average, caregivers provided 33 hours of informal care per
week to patients (SD 29 hours). On a scale from 0 to 10, their self-rated burden was 5.4. The average Care-related Quality of
Life utility was 72. Caregivers primarily indicated problems with daily activities, mental health, and physical health. Still, the
vast majority of caregivers (87%) derived fulfillment from providing care. Weekly societal costs of caregiving were on average
V636. Comorbidities contributed substantially to the caregiver time and burden.
Conclusions: Caring for a patient with AF is associated with substantial objective and subjective burden, but also provides
fulfillment from being able to care for a loved one.
Keywords: atrial fibrillation, caregiver burden, informal care, societal costs.
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Atrial fibrillation (AF) is a condition in which the heart rate is
rapid and irregular. In 2010, more than 33 million people world-
wide had AF.1 The number of patients with AF over the age of 55
years in the European Union is estimated to increase from 8.8
million in 2010 to 17.9 million in 2060.2 In Australia, patient
numbers are projected to double by 2050.3 AF-related hospitali-
zations have been increasing rapidly over the last years.3,4 Patients
with AF have an increased risk of other conditions such as stroke
and heart failure.5,6 Furthermore, AF is associated with increased
mortality risk.6,7 Also, patients with AF have a reduced quality of
life compared with the general population.8 Patients with AF more
frequently receive assistance from a caregiver than age-matched
controls, which is also related to the high frequency of comor-
bidities.9 As such, the condition not only affects the patient, but
the patient’s social environment as well. Care provided by the
patient’s social environment and not in a professional capacity is
called informal care. Providing informal care can have both
negative and positive effects on the caregiver’s well-being.10 On
the one hand, providing care might be burdensome, as caregivers
have to invest time to care for the patient or might need to15 - see front matter Copyright ª 2020, ISPOR–The Professional Society for
cess article under the CC BY license (http://creativecommons.org/licenses/bperform tasks with which they are not comfortable. In addition,
providing informal care might lead to physical and mental health
problems or financial difficulties for the caregiver. On the other
hand, caregivers might appreciate providing care for their loved
ones.11 In addition to caregiver well-being effects, providing
informal care has an economic societal impact, as time spent on
providing informal care has an opportunity cost. In economic
evaluations from a societal perspective, inclusion of costs related
to informal care is therefore important.
The literature on the burden of caregiving for patients with AF
is very limited. A literature review identified only 2 publications
on informal care for patients with AF, with one study focusing on
the need for informal care assistance and one study focusing on
the burden of caregiving.12 The latter study was conducted in the
United States in 80 patients and their caregivers, and found that
caregivers particularly had disrupted schedules and financial
problems.13 Evidence of the burden of caregiving for patients with
AF in other countries is not available, although cultural, de-
mographic, and socioeconomic differences between countries
might affect the supply of informal care and experienced burden
for caregivers. This study aims to quantify the burden for care-
givers of patients with AF in Germany, Italy, and the UK. TheHealth Economics and Outcomes Research. Published by Elsevier Inc. This is an
y/4.0/).
Table 1. Time cost per hour (in Euro) of informal care and hourly labor costs in Italy, Germany, and UK (2019 values).
Proxy good method Source Opportunity cost method Source Labor cost Source
Italy 10.08 22 8.41 21 28.37 29
Germany 20.91 23-27 17.19 24-26 35.08 29
UK 13.72 21 15.26 21 27.99 29
ECONOMIC EVALUATION 237current project on informal care in AF is the largest to date and the
first to focus on Western European countries.
Methods
Study Population
German, Italian, and UK caregivers of patients with self-
reported AF were recruited by an online sampling agency.
German and UK respondents had indicated to provide care for a
patient with AF before the start of the current study; Italian re-
spondents were specifically asked to indicate this in the inclusion
phase of the current study. Physician-confirmed diagnosis of AF
was not requested in this sample. Only adult caregivers (18 years
or older) who provided informal care in the last 2 consecutive
weeks before completing the survey or longer were included in
the sample. Data were collected in January 2020.
Measures
The iMTA Valuation of Informal Care Questionnaire (iVICQ)
formed the main part of the caregiver survey. The iVICQ is a non-
disease–specific instrument designed to measure the burden of
providing care, which contains questions on the objective burden
of caregiving, the subjective burden of caregiving, and the effects
on the health and well-being of caregivers.14 The self-rated burden
(SRB) instrument15 and the Care-related Quality of Life (CarerQol)
instrument16 are integral parts of the iVICQ questionnaire. The SRB
examines the burden of caregiving on a scale from 0 (not at all
straining) to 10 (much too straining). The CarerQol instrument
consists of 7 dimensions of caregiver burden with 3 levels (no,
some, and a lot). In addition, questions on caregivers’ activities of
daily living were included, consisting of 11 dimensions of activities
of daily living with 5 levels (ranging from “without difficulties” to
“not even with help from others”).
In addition to the burden-related questions, caregivers completed
an amended version of the iMTA Productivity Cost Questionnaire
(iPCQ), a non-disease–specific questionnaire to assess losses in pro-
ductivity due to illness resulting from providing informal care.17 Only
productivity losses due to illness resulting from providing care were
considered; absence from work for the provision of care was
excluded. Caregivers also were asked to answer questions about the
patient they were caring for (eg, patient’s age, gender, comorbidities,
living situation, AF type). In the survey, no distinction was made
regarding the origin of the need for informal care (ie, whether care
was related to AF or to potential comorbidities).
The survey was made available in English, German, and Italian. In
each of the 3 countries, the questionnaire was first tested in a small
portion (10%) of the desired sample size. No major changes were
needed after the initial testing phase. Respondents were asked to fill
in the survey only once. Because of the cross-sectional study design,
comparisons between treatments were not part of the analyses.
Analyses
Caregiver burden and quality of life
The objective burden was expressed in the volume (hours) of
informal care provided. The subjective burden of caregiving wasassessed using the SRB and the CarerQol instrument. The
CarerQol instrument was used to calculate caregiving utilities to
describe care-related quality of life in a single utility value be-
tween 0 and 100.18 The CarerQol tariffs are available for mul-
tiple countries, including Germany and the UK.19 For Italian
caregivers, the UK dataset was used. Process utility was
assessed to determine whether caregivers derived happiness
from providing care.11 This was calculated from the difference
between the current happiness of the caregiver compared with
the happiness of the caregiver if somebody were to take over
the provision of informal care. Both questions were measured
on a scale from 0 (completely unhappy) to 10 (completely
happy). The process utility therefore ranges from –10 to 10,
with negative values representing that caregivers would gain
happiness if informal care tasks were conducted by others and
positive values representing that caregivers derive happiness
from providing informal care.
Informal care costs
The proxy good method was used to calculate time costs of
caregiving. In the proxy good method, the unit cost of time rep-
resents the value of a close market substitute.20 In a scenario
analysis, informal care time was valued using the opportunity cost
method. In this method, the unit cost of caregiver’s time is set
equal to the value of the time forgone.20 Valuation of informal care
time was taken from scientific literature, using different values for
the 3 countries. The unit cost for UK and Italy (opportunity cost
method) was derived from a systematic literature review,21 in
which the Italian unit cost was set equal to the southern European
unit cost estimate. The Italian unit cost for proxy good method
was derived from a single Italian study.22 Several studies reported
German unit costs,23-27 from which the average value was calcu-
lated. Table 1 provides the hourly unit cost used in the analyses.
All costs are presented in 2019 values, when necessary inflation
correction using Harmonised Consumer Price Index figures from
Eurostat28 was applied. Travel costs was set at V0.20 per
kilometer.
To calculate the costs of lost productivity due to illness from
providing informal care, hourly labor costs were derived from
Eurostat29 and are provided in Table 1. Lost productivity was
calculated using the human capital method. In the human capital
method, productivity losses are assumed to be incurred up to a
person’s retirement. In a scenario analysis, the friction cost
method was used, in which productivity losses are limited to the
period it takes to replace the absent worker. Costs of informal care
time, travel, and productivity losses were expressed in cost per
1-week period.
Relationship between caregiver burden, health, and
costs
To assess the relation between caregiver burden (total hours
of informal care, SRB, CarerQol utility, and total costs of
informal care) and patients’ health status, regression analyses
were performed. In this respect, patient’s health status (visual
analogue scale), age, type of AF, duration of AF, whether pa-
tients lived in an institution, patient’s comorbidities, and the
Table 2. Caregiver and patient characteristics.
Total UK Italy Germany
Long-term caregiver 585 200 189 196
Caregiver characteristics
Gender (% female) 57.6 64.0 53.4 55.1
Age (y, mean) 46.8 [15.6] 51.2 [16.4] 44.2 [13.5] 44.9 [15.7]
Education
Low (%) 4.3 3.0 3.2 6.6
Middle (%) 46.2 29.0 48.2 61.7
High (%) 49.6 68.0 48.7 31.6
Partner (% yes) 83.1 83.5 85.7 80.1
Number of children 1.2 [1.2] 1.4 [1.2] 1.0 [1.0] 1.1 [1.3]
Health status (VAS: 0-10) 6.6 [1.9] 6.6 [1.9] 7.1 [1.6] 6.2 [2.1]
Activities of daily living (sum: 11-55) 16.9 [8.1] 16.7 [7.9] 15.5 [6.8] 18.4 [9.1]
Paid work (% yes) 59.0 48.5 62.4 66.3
Patient characteristics
Gender (% female) 49.7 50.0 50.3 49.0
Age (y, mean) 65.8 [20.5] 64.5 [21.1] 69.7 [17.0] 63.3 [22.4]
$70 y (%) 54.5 50.5 64.0 49.5
Health status (VAS: 0-10) 4.4 [2.1] 4.3 [2.0] 4.8 [1.8] 4.1 [2.3]
Duration AF (y) 10.0 [11.6] 9.7 [9.2] 11.1 [14.9] 9.2 [10.0]
Type AF
Paroxysmal (%) 18.0 18.5 15.9 19.4
Persistent (%) 24.6 17.0 30.2 27.0
Permanent (%) 45.5 48.5 42.3 45.4
Unknown to caregiver (%) 12.0 16.0 11.6 8.2
Comorbidity
Yes (%) 92.7 92.0 92.1 93.9
No (%) 5.0 7.0 5.3 2.6
Unknown to caregiver (%) 2.4 1.0 2.7 3.6
Polymedication
Yes (%) 79.2 82.5 71.4 83.2
No (%) 15.0 12.0 21.7 11.7
Unknown to caregiver (%) 5.8 5.5 6.9 5.1
Weight
#60 kg (%) 23.3 27.0 21.2 21.4
.60 kg (%) 71.5 61.5 77.8 75.5
Unknown to caregiver (%) 5.3 11.5 1.0 3.1
Note. Standard deviations are in brackets.
AF indicates atrial fibrillation; VAS, visual analogue scale.
238 VALUE IN HEALTH FEBRUARY 2021duration of informal care were used as independent variables.
The total hours of informal care were used as an additional
independent variable in the analyses for SRB and CarerQol
utility. Variables were included in the final model using back-
ward regression. Backward selection has the risk of overfitting
to the sample characteristics, but was mainly used as a tool to
estimate burden of care within this sample attributable to AF.
To resemble the skewness of the data for the dependent vari-
ables, a gamma generalized linear estimation (using log link and
the gamma family) model was used. Model fit was assessed
using visual inspection of density plots, mean absolute error,
and root square mean error, and fit of both ordinary least
squares and gamma generalized linear estimation models are
presented in the Appendix in Supplemental Materials found at
https://doi.org/10.1016/j.jval.2020.09.011.
Analyses were performed using Stata 16.0 (Statacorp, College
Station, TX).Results
Table 2 shows the characteristics of the caregivers and the
patient they were caring for. The sample consisted of 585 care-
givers (200 UK, 189 Italian, and 196 German caregivers). Care-
givers were most often female and on average 47 years old (range
18-84). The majority of caregivers had a partner. Caregivers’
problems with activities of daily living were limited.
Patients had an average age of 66 years; 41% of patients were
75 years of age or older. Patients had AF for 10 years, and almost
50% of patients had permanent AF. In all 3 countries, more than
92% of patients had one or more comorbidities, most often car-
diovascular disease (55%), respiratory diseases (30%), arthrosis
(28%), and diabetes (25%). Patient and caregiver characteristics
were fairly similar between countries.
Table 3 shows the properties of informal care provided. The
patient was the mother or father of the caregiver in 35% of cases,
Table 3. Informal care properties.
Total UK Italy Germany
Relationship with patient (%)
Spouse 24.1 42.5 6.9 21.9
Mother or father 34.7 28.0 38.6 37.8
Mother-in-law or father-in-law 12.7 11.5 16.4 10.2
Daughter or son 3.3 3.5 0.5 5.6
Another family member 15.4 9.5 23.8 13.3
Other 9.9 5.0 13.8 11.2
Duration (mo, mean) 65.6 [73.7] 83.5 [84.0] 60.1 [65.5] 52.8 [66.3]
Days/wk (mean) 5.0 [1.9] 5.4 [1.9] 4.5 [2.0] 5.2 [1.8]
Objective burden (h/wk)
Total hours of informal care* 33.2 [29.4] 37.3 [32.5] 30.5 [27.9] 31.6 [27.0]
Household activities 15.7 [14.6] 18.6 [15.5] 12.5 [12.4] 15.8 [15.0]
Personal care 8.8 [10.9] 9.9 [12.4] 8.9 [10.9] 7.6 [9.0]
Practical support 8.7 [10.4] 8.8 [11.1] 9.1 [10.6] 8.2 [9.5]
Hours by other informal caregivers 3.9 [13.1] 2.4 [8.7] 5.2 [16.7] 4.3 [12.5]
Opportunity time spent if not spent on
caregiving (h/wk)
Paid work 9.2 [15.9] 9.6 [18.5] 9.9 [15.7] 8.0 [13.0]
Unpaid work 10.1 [17.7] 13.2 [24.1] 7.5 [11.8] 9.3 [14.0]
Leisure time 13.9 [16.6] 14.5 [14.7] 13.1 [16.4] 14.2 [18.5]
Subjective burden
Self-rated burden (0-10) 5.4 [2.5] 5.1 [2.7] 5.3 [2.3] 5.7 [2.4]
Process utility (–10 to 10) 0.1 [3.1] 0.5 [3.3] 0.0 [2.8] 20.1 [3.1]
Negative process utility (%) 39.3 35.5 38.6 43.9
Neutral process utility (%) 22.2 24.0 26.5 16.3
Positive process utility (%) 38.5 40.5 34.9 39.8
CarerQol utility (0-100) 71.7 [19.5] 69.1 [19.5] 75.0 [18.9] 71.1 [19.7]
Note. Standard deviations are in brackets.
*For 18 respondents (3%), total hours of care were maximized at 126 h/wk (18 h/d 3 7 d/wk), as a larger number of hours per week provided by a single caregiver was
considered unrealistic.
Figure 1. Scores on Care-related Quality of Life dimensions.
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Table 4. Weekly costs of informal care (all costs in Euros, 2019 values).
Total UK Italy Germany
Mean Range Mean Range Mean Range Mean Range
Time costs (proxy good) 496 10-2635 512 14-1729 308 10-1270 660 63-2635
Travel costs 8 0-451 8 0-451 8 0-280 7 0-280
Productivity costs HCM 133 0-2487 98 0-1308 98 0-1704 203 0-2487
Total costs 636 14-3493 618 14-2997 414 20-1993 869 63-3493
Time costs (opportunity costs) 459 8-2166 570 15-1923 258 8-1060 542 52-2166
Productivity costs FCM 116 0-2487 84 0-1308 96 0-1704 166 0-2487
FCM indicates friction cost method; HCM, human capital method.
240 VALUE IN HEALTH FEBRUARY 2021and in 24% the patient was the caregiver’s spouse. Remarkable
differences between countries were observed; in Italy the patient
was the caregiver’s spouse in less than 7% of the sample, whereas
in the UK more than 42% of caregivers cared for their spouse. The
average duration of caregiving was 66 months (5.5 years), with
caregivers from the UK indicating care for a longer period than in
the other countries.
On average, caregivers provided 33 hours of informal care per
week, with substantial variation between caregivers (SD 29.4).
Total hours of informal care had a right-skewed distribution, with
some caregivers indicating many hours of care per week. The
median volume of informal care provided was 22 hours per week.
The differences in the average hours of informal care between
countries were limited. Approximately half of the informal care
time was spent on household activities (eg, food preparation,
cleaning, or taking care of children), and the remainder was
distributed evenly over personal care (eg, dressing, washing, or
going to the toilet) and practical support (eg, healthcare visits,
organizing help, or transportation). If not providing care,Table 5. Regression output total hours of informal care, caregiver b
Total hours Caregiver
Coeff P value Coeff
Constant 41.075 ,.001 4.457
Patient’s health (VAS 0-10) NS NS
Patient’s age 0.995 .002 NS
Duration AF NS 1.005
Paroxysmal AF NS NS
Permanent AF NS 0.893
Patient institutionalized NS 1.181
Cardiovascular comorbidity NS NS
Arthrosis comorbidity NS 1.129
CNS comorbidity NS NS
Cancer comorbidity NS 1.139
Diabetes comorbidity 1.238 .009 1.167
Respiratory comorbidity 1.294 .001 NS
Other comorbidities NS NS
Duration informal care NS 0.999
Total hours informal care 1.003
AF indicates atrial fibrillation; CarerQol, Care-related Quality of Life; CNS, central nervcaregivers would have spent this time on leisure (42%), unpaid
work (30%), and paid work (28%).
Caregivers’ self-rated burden was 5.4; 56% of caregivers had a
burden of 5 or higher. Similar proportions of patients had a pos-
itive or negative process utility, signifying patients deriving or
losing happiness from providing informal care, respectively. The
average process utility was 0, indicating that, on average, care-
givers’ happiness was not affected by providing care. However,
only 22% of caregivers had a process utility of 0, indicating that the
average value did not reflect differences within the sample.
Caregivers had an average caregiver utility of 72, which was
similar between the countries studied. Still, there was consider-
able variation between caregivers (SD 19.5). The median care-
giving utility was 75, and 36% of caregivers had a caregiver utility
below 70.
Figure 1 shows the scores on the CarerQol dimensions. The
majority of caregivers (87%) derived some or a lot of fulfillment
out of providing informal care. Problems in daily activities was the
most frequently reported problem by caregivers; 71% of caregiversurden, CarerQol utility, and total costs of informal care.
burden CarerQol utility Total costs
P value Coeff P value Coeff P value
,.001 57.654 ,.001 1452.001 ,.001
1.012 .044 0.942 .001
1.004 ,.001 0.988 ,.001
.009 0.998 .023 NS
NS NS
.005 NS




.030 0.933 .038 NS
.001 NS 1.397 ,.001




ous system; NS, nonsignificant; VAS, visual analogue scale.
ECONOMIC EVALUATION 241reported some or a lot of problems in this area. Most caregivers
experienced some or a lot of mental or physical health problems
(60% and 67%, respectively). Scores on CarerQol dimensions were
largely comparable between countries; only on the mental and
physical health dimensions did the Italian caregivers slightly
deviate from caregivers in the UK and Germany.
Table 4 shows the costs associated with providing informal
care. Total costs of informal care were on average V636 per week,
varying as V414 in Italy, V618 in the UK, and V869 in Germany.
The average hides substantial differences between caregivers
(range V14-V3493). As is often the case for cost estimates, the
distribution of costs is skewed with relatively low costs for many
caregivers and high costs for a few caregivers. The median costs of
informal care per week were V432. Time costs calculated with the
proxy good method were approximately V500. There were
remarkable differences between countries; German time costs
were more than twice as much as Italian costs. Because caregiving
timewas similar, the differences were explained by the differences
in valuation of informal care time. Travel costs were limited,
because caregivers and patients shared a household (59%) or
caregivers lived near the patient. In total, 59% of caregivers had a
paid job. Productivity costs due to illness resulting from informal
care were V133 per week. Long-term absence was the biggest
contributor of total productivity costs (V55 per week; 42% of total
productivity costs). Unpaid work (V38 per week; 29%), short-term
absence (V20; 15%) and presenteeism (V19; 15%) were the other
components of productivity costs. Productivity costs were higher
in Germany than in the UK and Italy because of the higher wage
rates in Germany. Furthermore, German caregivers most
frequently had a paid job (Table 2). When using the opportunity
costs method to value informal care time, care time costs were
slightly lower compared with using the proxy good method. Using
the friction cost method rather than the human capital method
resulted in lower productivity costs because productivity costs for
caregivers with long-term absences were zero in the friction cost
method.
Table 5 shows the results of the regression analyses with the
total hours of informal care, caregiver burden, CarerQol utility
values, and total costs of informal care as dependent variables.
Patient’s age was negatively related to the total hours of care.
Patients who had comorbid diabetes and respiratory diseases
received 1.2 times and 1.3 times more hours of informal care
each week, respectively, compared with patients without these
comorbidities. Other comorbidities did not significantly affect
the hours of informal care received. Caregiver burden was
positively associated with duration of AF. Caregiver burden was
higher for caregivers who provided care to patients with
arthrosis, cancer, diabetes. In addition, caregiver burden was
higher for patients who were institutionalized and lower for
patients who had permanent AF. Caregiver burden was nega-
tively associated with duration of informal care. The total hours
of informal care provided were positively related to caregiver
burden. Caregivers for institutionalized patients had a lower
CarerQol utility than caregivers for patients who were living at
home. Caregivers for patients with respiratory comorbidity also
had a lower CarerQol utility than caregivers for patients without
respiratory comorbidity. Total hours of care and duration of AF
were negatively associated with CarerQol utility. Total informal
care costs were lower for caregivers of patients with worse
health status and older patients. Informal care costs for care-
givers of patients with cardiovascular, diabetes, and respiratory
comorbidities were higher than for caregivers of patients
without these comorbidities.
When canceling out the effects of comorbidities and other
significant predictors, and using the average population values,the expected hours of care, caregiving burden, CarerQol utility,
and costs of informal care were related to AF. The predicted hours
of care related to AF were 29.5 per week. Caregiver burden related
to AF was 4.5. AF-related CarerQol utility was 73.9, and costs
related to informal care for AF were V504 per week.Discussion
Comparison with Other Studies
The current study on AF caregivers was the largest to date and
conducted in real-world populations in Germany, Italy, and the UK
(n = 585). The median age (71 years in the current study vs 70-73
years in the clinical trials) was similar comparedwith the large trial
populations with anticoagulants (nonvitamin K antagonist oral
anticoagulants; NOACs) for the treatment of AF, but the proportion
of women in this study (ie, 50%) was higher than in the nonvitamin
K antagonist oral anticoagulants clinical trials (36%-40% female
patients).30-33 The proportion of patientswith paroxysmal AF in the
current study (18%) was in the range of the proportion observed in
the clinical trials (15%-33%). Importantly, most patients had
comorbidities both in the current study and in the pivotal trials.
Similar to the pivotal trials,most patients (55%) in the current study
had cardiovascular comorbidities, but specific disease comorbid-
ities could not be singled out in the current study, complicating a
more detailed comparison with the pivotal trials.
One earlier study by Coleman et al examined the burden of
caregiving for patients with AF in the United States.13 Coleman
et al did not present the absolute hours of informal care provided.
In their study, 40% of caregivers provided care for more than 4
hours per week, whereas in this study more than 96% of caregivers
indicated to provide this amount of care, which showed that the
absolute burden of caregiving might be higher in the current
study. Caregiver burden dimensions were measured with a
different instrument and on a different scale. Burden was mostly
related to “disrupted schedule” in the US study and “problems
with daily activities” in the current study, which appear to be
similar dimensions. The burden of informal care has been studied
in related indications. A systematic review found 5 studies on
caregivers for stroke survivors, who received on average of 24
hours of care per week.21 Self-rated burden in caregivers for Dutch
stroke survivors was much lower than the SRB in caregivers for
patients with AF (2.9 rescaled to 0-10 scale vs 5.4, respectively),
and caregivers provided less care for stroke survivors than for
patients with AF (23.8 hours vs 33.2 hours, respectively).34
Spanish stroke survivors received 51.2 hours of care per week,
and thus received more care per week than patients with AF.35
Patients with symptomatic chronic heart failure received 44.9
hours of informal care per week from their informal caregiver.36
Nonetheless, precaution is necessary when making international
comparisons due to demographic, cultural, and socioeconomic
differences between countries.
This study found an average CarerQol utility value of 71.7. A
systematic literature review assessed caregiver utilities with the
CarerQol and other instruments.37 Mean CarerQol utility values
ranged from 79.2 in the Dutch population with caregivers for
nonspecified diseases, 84.7 for mothers and 89.2 for fathers of
patients with cystic fibrosis in Ireland, and 70.1 for caregivers
providing care for Dutch patients with dementia. Median values in
Dutch nonspecified diseases were 83.1 and in Dutch patients in
rehabilitation were 83.9 compared with the median value in the
current study of 75.3. Except for the caregivers of patients with
dementia, CarerQol utilities were thus lower than in other pop-
ulations. This might be explained by the large proportion of
242 VALUE IN HEALTH FEBRUARY 2021patients with comorbidities in the current study, which is
commonly observed in AF.
Limitations
The sample consisted of self-reported caregivers. Physician-
confirmed AF diagnosis was not requested, but respondents
were allowed to confirm the diagnosis with the patient or a
physician. The survey contained questions about patients’ health,
comorbidities, and AF characteristics. Although there was an opt-
out option for most questions, caregivers might have had diffi-
culties in answering these questions and might have provided
lower-quality responses than a physician or patients themselves
would have provided. Most caregivers were unable to determine
the CHADS-2 score of the patient they cared for, which would have
been a good indicator of severity. Still, the majority of caregivers
were able to identify type of AF and most other characteristics. For
the identification of comorbidities, a trade-off was made between
specificity of disease categories and caregivers’ ability to respond.
More specific disease categories would be desired to quantify the
impact of specific indications (eg, congestive heart failure) on
caregivers, but caregivers might encounter difficulties in identi-
fying patient’s comorbidities on that level of detail. The active
involvement of patients or treating physicians would have been
needed to ensure the quality of responses.
More than 90% of the patient population had comorbidities.
Given the indication and the relatively high age of patients this is
not surprising, but it does complicate the interpretation of the
results. The total hours of care provided are not related to AF only,
and subjective burden, CarerQol utility, and informal care costs are
affected by comorbidities as well; the descriptive statistics on
caregiver burden and informal care costs therefore also reflect the
burden related to comorbid diseases. However, in practice, it
would be impossible to single out caregiver tasks and burden
according to AF or other diagnoses, hence in the survey such a
distinction was not asked for. The impact of other factors can only
be controlled for once data are collected. In the current study,
regression analyses showed the significant contribution of various
comorbidities on absolute and subjective burden.
Selection bias cannot be ruled out, but it is unclear how this
might have affected results; on one hand, more burdened care-
givers might be inclined more to express their situation, but on
the other hand might also have had limited time or energy left to
participate in the study. Assessing caregiver burden alongside
future clinical trials is necessary to reduce potential selection bias.
Implications
Most patients with AF who receive informal care are elderly
patients who have comorbidities such as diabetes, respiratory
diseases, and other cardiovascular diseases. Societal costs of
informal care of AF are shown to be substantial, demonstrating
that the elderly patient is often an ecosystem rather than a single
affected unit and that a less favorable clinical outcome will affect
both the patient with AF and the caregiver. Hence, when per-
forming an economic evaluation from a societal perspective, not
only medical costs but also inclusion of informal care costs is
pivotal. When interventions are expected to affect the need for
informal care, this would also translate into societal cost savings.
The current study further showed that caregivers of patients
with AF provided a large amount of informal care. Although the
majority of caregivers indicated they receive fulfillment from
providing informal care, caregiver quality of life was shown to be
lower than in many other indications. Caregivers exposed to such
demanding caregiving situations face a risk of negative effects on
their own health, becoming overburdened and eventually nolonger being able to provide necessary informal care. Recognition
of caregiver burden and providing assistance to caregivers might
help to prevent negative health effects in caregivers and to ensure
that caregivers remain motivated in performing their important
caregiving tasks. Such assistance might come in the form of
respite care (ie, giving caregivers some time off from providing
informal care). This would be particularly useful for caregivers
who face a high burden of caregiving and do not retrieve fulfill-
ment from providing care.38 Attention for caregiver burden and
policies to deal with caregiver burden are especially relevant in
light of the increasing prevalence of AF in the coming years.
Conclusions
This study shows that caregivers for patients with AF provided
a considerable amount of informal care. Providing care can be
burdensome to caregivers but can also provide fulfillment to them.
Both absolute burden and subjective burden were similar among
the UK, Italy, and Germany. Informal care also results in societal
costs due to time costs of caregivers and absence fromwork due to
health issues resulting from informal care.
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